BIOMAT Database Logo BIOMAT Database Logo

Noncompliance with antihypertensive therapy. Economic consequences. 1996

T L Skaer, and D A Sclar, and L M Robison
College of Pharmacy, Washington State University, Pullman, USA.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D010349 Patient Compliance Voluntary cooperation of the patient in following a prescribed regimen. Client Adherence,Client Compliance,Non-Adherent Patient,Patient Adherence,Patient Cooperation,Patient Noncompliance,Patient Non-Adherence,Patient Non-Compliance,Patient Nonadherence,Therapeutic Compliance,Treatment Compliance,Adherence, Client,Adherence, Patient,Client Compliances,Compliance, Client,Compliance, Patient,Compliance, Therapeutic,Compliance, Treatment,Cooperation, Patient,Non Adherent Patient,Non-Adherence, Patient,Non-Adherent Patients,Non-Compliance, Patient,Nonadherence, Patient,Noncompliance, Patient,Patient Non Adherence,Patient Non Compliance,Patient, Non-Adherent,Therapeutic Compliances,Treatment Compliances
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive

Related Publications

T L Skaer, and D A Sclar, and L M Robison
Some economic consequences of noncompliance.
December 2001, Current hypertension reports,
T L Skaer, and D A Sclar, and L M Robison
[Economic consequences and human aspects of antihypertensive treatment].
February 1988, Ugeskrift for laeger,
T L Skaer, and D A Sclar, and L M Robison
The implications of noncompliance with antihypertensive medication.
August 1996, Drugs,
T L Skaer, and D A Sclar, and L M Robison
Renal consequences of antihypertensive therapy.
March 1991, Seminars in nephrology,
T L Skaer, and D A Sclar, and L M Robison
Metabolic consequences of antihypertensive therapy.
February 1987, The Journal of the American Osteopathic Association,
T L Skaer, and D A Sclar, and L M Robison
Metabolic consequences of antihypertensive therapy.
May 1983, Annals of internal medicine,
T L Skaer, and D A Sclar, and L M Robison
Cost and consequences of noncompliance with osteoporosis treatment among women initiating therapy.
April 2015, Current medical research and opinion,
T L Skaer, and D A Sclar, and L M Robison
Cardiovascular consequences of primary antihypertensive therapy with prazosin hydrochloride.
January 1984, The American journal of cardiology,
T L Skaer, and D A Sclar, and L M Robison
Factors associated with noncompliance of patients taking antihypertensive medications.
March 1995, Hospital pharmacy,
T L Skaer, and D A Sclar, and L M Robison
Economic consequences of surfactant therapy.
January 1993, Journal of perinatology : official journal of the California Perinatal Association,
Copied contents to your clipboard!